NCT04733482

Brief Summary

This study aimed to explore the effects of cosmetic care on body image (BI), and social avoidance and distress (SAD) in young Chinese breast cancer patients, aged 18-40 years old, receiving adjuvant chemotherapy. This was a single-center, 2-arm quasi-experimental study. The control group received usual care, while cosmetic care was added to the intervention group. The primary outcomes were BI and SAD accompanying chemotherapy, and the secondary outcome was the appearance satisfaction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 3, 2015

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2015

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2017

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

January 24, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 2, 2021

Completed
Last Updated

February 2, 2021

Status Verified

January 1, 2021

Enrollment Period

8 months

First QC Date

January 24, 2021

Last Update Submit

January 28, 2021

Conditions

Keywords

body imagecosmetic carepsychosocial supportsocial avoidance and distressyoung breast cancer

Outcome Measures

Primary Outcomes (2)

  • Body image scale

    Body image (BI) was assessed using the body image scale. It is a 10-item self-assessment scale, measuring cancer patients' perception of their appearance. The minimum and maximum values of the scale are 0 and 30. A higher score signifies a worse BI.

    Change from baseline to half of the cycle of chemotherapy and the end of cycle of chemotherapy (each cycle is 21 days, and there were 4-6 cycles totally).

  • Social avoidance and distress scale

    Social avoidance and distress (SAD) was assessed using social avoidance and distress scale, which contains 28 items. The total score in the scale ranges from 0 to 28. A higher score means greater SAD.

    Change from baseline to half of the cycle of chemotherapy and the end of cycle of chemotherapy (each cycle is 21 days, and there were 4-6 cycles totally.)

Secondary Outcomes (1)

  • Appearance satisfaction questionnaire

    The end of cycle of chemotherapy (each cycle is 21 days, and there were 4-6 cycles totally.).

Study Arms (2)

Control group

NO INTERVENTION

Participants in the control group received usual care during adjuvant chemotherapy. The usual care consisted of written information and verbal guidance on the adverse effects of chemotherapy and related psychological reactions.

Cosmetic care group

EXPERIMENTAL

Participants in the intervention group received cosmetic care in combination with usual care. The cosmetic care was a 3-hour, free-of-charge beauty activity, including face moisturizing steps, make-up, wigs, and breast prostheses wearing. It was provided by professional cosmeticians at a cosmetic training base before the patients finished half of their chemotherapy cycle.

Behavioral: Cosmetic care

Interventions

Cosmetic careBEHAVIORAL
Cosmetic care group

Eligibility Criteria

Age25 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Primary breast cancer patients
  • Aged 18-40 years old, who received surgery and adjuvant chemotherapy in our department
  • No prior neoadjuvant chemotherapy
  • Being available to communicate by the novel social application "Wechat"

You may not qualify if:

  • Diagnosis of psychiatric or intellectual impairment
  • Having a history of neoadjuvant therapy
  • Having distant metastasis
  • ECOG\<2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, 200032, China

Location

Study Officials

  • Shengqun Hou, Master

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Zhenqi Lu, Master

    Fudan University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director of nursing department in Fudan University Shanghai Cancer Center

Study Record Dates

First Submitted

January 24, 2021

First Posted

February 2, 2021

Study Start

January 3, 2015

Primary Completion

September 10, 2015

Study Completion

September 10, 2017

Last Updated

February 2, 2021

Record last verified: 2021-01

Locations